Floatz logo

Emestedastat

MDD

Actinogen MedicalSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the MDD cohort.

Asset / SponsorPhaseRating
Suvorexant
Marianne Goodman
Phase 4BB
Rosuvastatin
Ain Shams University
Phase 3B
lv232
Vigonvita Life Sciences
Phase 2B
ZINC SULFATE
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
N/AD

Same molecule, other indications

Emestedastat is also rated in:

Alzheimer diseaseDormant
BB
Indicative ·
69 / 100
View asset →
cognitive disorderDormant
BB
Indicative ·
64 / 100
View asset →
Alzheimer diseaseDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →